title: Switching to low dose of plasma-derived factor VIII/vWF concentrates with Confact(®) -F as salvage immune tolerance induction in haemophilia A patients with inhibitors: five case reports from Japan.
authors.affiliation: Department of Hematology Ogikubo Hospital, Suginami-ku, Tokyo, Japan.
authors.forename: A
authors.initials: A
authors.lastname: Nagao
authors.affiliation: Department of Pediatrics Sapporo Tokushukai Hospital, Sapporo, Hokkaidou, Japan.
authors.forename: T
authors.initials: T
authors.lastname: Oka
authors.affiliation: Department of Hematology Ogikubo Hospital, Suginami-ku, Tokyo, Japan.
authors.forename: H
authors.initials: H
authors.lastname: Hanabusa
mesh_terms: D000906:Antibodies / Q000276:immunology*; D002648:Child; D002675:Child, Preschool; D004305:Dose-Response Relationship, Drug; D005169:Factor VIII / Q000276:immunology*; D006467:Hemophilia A / Q000150:complications / Q000276:immunology*; D006470:Hemorrhage / Q000209:etiology; D006801:Humans; D007108:Immune Tolerance; D007231:Infant, Newborn; D007564:Japan; D016879:Salvage Therapy; D014841:von Willebrand Factor / Q000276:immunology*
chemical_list: D000906:Antibodies; D014841:von Willebrand Factor; D005169:Factor VIII